Johnson & Johnson’s $2B Plant Boosts Wilson Jobs
Johnson & Johnson's $2 billion investment in Wilson will create 420 jobs, boosting the local economy and life sciences sector.
- Latest
- Trending
Johnson & Johnson's $2 billion investment in Wilson will create 420 jobs, boosting the local economy and life sciences sector.
Vir Biotechnology appoints Jason O’Byrne as CFO, effective October 2, 2024, boosting financial strategy and leadership.
Boehringer Ingelheim acquires Saiba Animal Health, boosting pet R&D with innovative therapeutic vaccines.
Discover why Fortress Biotech's stock is a smart choice for investors seeking both momentum and value in today's market.
Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO as market hopes for rate cuts and reduced volatility rise.
Tecan reports lower H1 2024 sales, revises full-year outlook due to biopharma sector weakness and market challenges in China.
Fortress Biotech reveals Q2 2024 financials with key FDA updates; NDA and BLA filings signal growth in dermatology and oncology.
Legend Biotech reports better-than-expected quarterly earnings, $0.49 EPS above estimates, with significant revenue growth.
Veracyte's Q2 revenue surged 27% to $114.4M, fueled by strong demand for genomic tests. Full-year guidance raised to $432M-$438M.
Novo Nordisk's $4.1B Clayton investment creates 1,000 jobs, boosts local economy, and enhances life science growth in North Carolina.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.